🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

🧪

Trial Match

Clinical trials test new treatments — sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

🎯 Match trials to me

30 recruiting trials

for Dementia, Mild

Longitudinal Profiling of Plasma-Derived Glial Extracellular Vesicles in Alzheimer's Disease NCT07803055NA1 site📍 Rome Fondazione Policlinico Universitario Agostino Gemelli IRCCS · Tests: blood sampling Reducing African American's Alzheimer's Risk Through Exercise-Mild Cognitive Impairment (RAATE-MCI) NCT04956549NA1 site📍 Baton Rouge Pennington Biomedical Research Center · Tests: Physical activity program, Successful Aging Closed-Loop Brain Stimulation as a Potential Intervention for Cognitive Decline NCT05907343NA1 site📍 Austin University of Texas at Austin · Tests: Closed-loop TBS, Open-loop TBS Neurocognitive Assessment Platform 4 Alzheimer NCT07272811n/a1 site📍 Milan IRCCS San Raffaele Positive Psychology for Early Cognitive Decline: Effects on Cognitive and Brain Function NCT07289061NA1 site📍 Thessaloniki Aristotle University Of Thessaloniki · Tests: Positive Psychology Intervention, Treatment as usual (TAU) Integrating Metabolism, Connectivity, and Mesoscale Imaging at Ultra-high Field to Decipher Mechanisms of Resilience and Neurodegeneration in Neurological Diseases and Healthy Aging NCT07202494n/a1 site📍 Marseille Assistance Publique Hopitaux De Marseille · Tests: Imaging Techniques (MRI 3T & 7T, Functional, Structural, and Metabolic Imaging) PUMCH Dementia Longitudinal Cohort Study NCT05023564n/a1 site📍 Beijing Peking Union Medical College Hospital Mazdutide in Type 2 Diabetes With Early-Stage Cognitive Impairment (LIGHT-COG Study) NCT07083154Phase 38 sites📍 Changsha📍 Changzhou📍 Nanjing The Affiliated Nanjing Drum Tower Hospital of Nanjing Unive… · Tests: Mazdutide, Placebo Elucidating the Role of Cholinergic Degeneration in Cognitive Fluctuations in Lewy Body Dementia NCT07284290Phase 41 site📍 Richmond Virginia Commonwealth University · Tests: Syn-One skin biopsy, Multi modal MRI, Assessment of dynamic EEG features over 48-hour periods across all study aims, Pl… Daridorexant to Treat Insomnia in Patients With Mild Cognitive Impairment and Mild to Moderate Alzheimer Disease NCT05924425Phase 41 site📍 Montpellier University Hospital, Montpellier · Tests: Daridorexant 50 mg, Placebo, Polysomnography, Neuropsychological assessment, Questionnaires on sleep and behavioural pr… Fasudil Trial for Treatment of Early Alzheimer's Disease (FEAD) NCT06362707Phase 26 sites📍 Tromsø📍 Oslo📍 Haugesund Helse Stavanger HF · Tests: Fasudil, Placebo Clinical Cohort of Memory Disorders NCT07880275n/a1 site📍 Seoul Yonsei University Study to Understand Novel Biomarkers in Researching Dementia NCT06547099n/a1 site📍 St Louis Washington University School of Medicine · Tests: Clinical tau PET, Clinical amyloid test, Research blood collection, Cognitive assessments Exploratory Study of Low-Dose Whole-Brain Radiation Therapy With HeLaXON 1X in Patients With Mild Alzheimer's Disease Dementia NCT07863011NA1 site📍 Cheonan ReadyCure Inc. · Tests: HeLaXON 1X Low-Dose Radiation Therapy, Sham HeLaXON 1X Procedure Effects of Transcranial Focused Ultrasound Stimulation (tFUS) on Neurological and Cognitive Outcomes in Parkinson's Disease NCT07207122NA4 sites📍 Tucson📍 Santa Monica📍 Gainesville Sanmai Technologies PBC dba Sanmai · Tests: Gen0Bh Transcranial Focused Ultrasound System (Active), Gen0Bh Transcranial Focused Ultrasound System (Sham) Cardiac Amyloid Deposits and Heart Dysfunction in Alzheimer's Disease NCT07154394n/a1 site📍 Essen University Hospital, Essen Prevalence of Mild Cognitive Impairment and Dementia in Patients Admitted to Non-neurological Rehabilitation Wards NCT07731334NA3 sites📍 Florence📍 Milan📍 Milan Fondazione Don Carlo Gnocchi ETS · Tests: Cognitive and clinical screening, Extended neuropsychological assessment, Blood biomarker sampling and APOE genotyping,… An Efficacy and Safety Study of Sodium Oligomannate (GV-971) for the Treatment of Alzheimer's Disease NCT05908695Phase 450 sites📍 Huainan📍 Beijing📍 Beijing Green Valley (Shanghai) Pharmaceuticals Co., Ltd. · Tests: GV-971, Placebo Retinal Imaging in Neurodegenerative Disease NCT03233646n/a1 site📍 Durham Duke University · Tests: Retinal and Choroidal Imaging ALA-enriched Nutrition for Prevention of Cognitive Decline in APOE4 Older Adults NCT07392723Phase 21 site📍 New Brunswick Michal Schnaider Beeri, Ph.D. · Tests: Alpha-Linolenic Acid (2.6 g/day), Placebo Control Group Repurposing Siponimod for Alzheimer's Disease NCT06639282Phase 21 site📍 Phoenix St. Joseph's Hospital and Medical Center, Phoenix · Tests: Siponimod, Placebo Shanghai Non-pharmacological Intervention for Mild Cognitive Impairment and Mild Alzheimer's Disease NCT05887674NA1 site📍 Shanghai Ruijin Hospital · Tests: Diet intervention, Exercise, Cognitive training A Study of Zunveyl on Safety, Tolerability, Neuropsychiatric Symptoms, and Caregiver Distress in Alzheimer's Disease (RESOLVE) NCT07633470Phase 422 sites📍 Irvine📍 Orange📍 Aventura Alpha Cognition, Inc · Tests: Zunveyl® Pulsed Electromagnetic Field Treatment In Patients With Alzheimer's Disease NCT05295615NA1 site📍 Hackensack Herrick Medical LLC · Tests: ECHS AD Device Understanding Brain Mechanisms Involved in Autobiographical Memory NCT05710549NA1 site📍 Geneva Lucie Bréchet · Tests: high-density electroencephalography (hdEEG), Transcranial alternating current stimulation (tACS) Wayfinding Intervention and Long-Term Memory NCT05625425NA1 site📍 San Francisco University of California, San Francisco · Tests: LabyrinthVR software, Placebo Games software, Labyrinth Tablet software, Labyrinth VR wireless Exercise as a Primer for Brain Stimulation in Vascular Cognitive Impairment No Dementia (VCIND) NCT05079464NA1 site📍 Toronto Sunnybrook Health Sciences Centre · Tests: tDCS, Exercise, Sham stimulation, Treatment as usual An Evaluation of Treatments for Sustained Clinical Response (18 Months) in Symptomatic Alzheimer's Disease NCT07724132Phase 32 sites📍 Cambridge📍 Chertsey University College, London · Tests: Placebo, Atomoxetine, Metformin 1000 mg Oral Tablet The Feasibility and the Efficacy of the Full-immersive Virtual Reality Cognitive Training in Patients With Mild or Moderate Dementia NCT07033468NA1 site📍 New Taipei City Chang Gung Memorial Hospital · Tests: VR-WLC, CTL-VR The Effect of Urolithin A (Mitopure®) on Alzheimer's Disease NCT07842146NA1 site📍 Prague University Hospital, Akershus · Tests: Urolithin A, Placebo Control
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy